Michael I Ruxin insider trades: Haemonetics (HAE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 4, 2010 | HAE | ↑ Buy | 215 | $46.34 | $10K | Direct | Nov 8, 2010 (4d) |
| Sep 23, 2009 | GLOB | ↓ Sell | 300,000 | $1.00 | $300K | Direct | Sep 25, 2009 (2d) |
| Oct 4, 2005 | GLOB | ↑ Buy | 1,000 | $920.00 | $920K | Direct | Oct 6, 2005 (2d) |
| Oct 3, 2005 | GLOB | ↑ Buy | 1,000 | $950.00 | $950K | Direct | Oct 5, 2005 (2d) |
| Oct 3, 2005 | GLOB | ↑ Buy | 1,000 | $950.00 | $950K | Direct | Oct 5, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HAE insiders
Open-market trades in the last 12 months
About Michael I Ruxin's insider trades
Michael I Ruxin is VP Global Software Strategies at Haemonetics (HAE). Since Oct 3, 2005, Michael has reported 4 open-market purchases worth $2.8M and 1 sale worth $300K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings), gifts (4 filings), option exercises (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HAE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.